Key result
Pulsatile pump flow in an ex-vivo extracorporeal circulation model resulted in increased hemolysis compared to non-pulsatile flow after 6 hours.
Why the study?
Pulsatile extracorporeal circulation systems are increasingly used to improve hemodynamics, but their effects on hemolysis, inflammation, and coagulation remain largely unknown.
Does pulsatile pump flow compared to non-pulsatile flow affect hemolysis, inflammation, and coagulation in an ex-vivo human blood model of extracorporeal circulation?
Does pulsatile pump flow compared to non-pulsatile flow affect hemolysis, inflammation, and coagulation in an ex-vivo human blood model of extracorporeal circulation?
Answers are grounded in this paper and cite their sources.
Pulsatile flow in extracorporeal circulation leads to increased hemolysis over time in an ex-vivo model, suggesting caution and appropriate monitoring for prolonged clinical use.
Introduction The application of extracorporeal circulation (ECC) systems is known to be associated with several implications regarding hemolysis, inflammation, and coagulation. In the last years, systems with pulsatile blood flow are increasingly used with the intention to improve hemodynamics in reperfusion. However, their implications on the aforementioned aspects remain largely unknown. To investigate the effects of pulsatility, this ex-vivo study was initiated. Methods Test circuits (primed with human whole blood) were set up in accordance with the recommendations of international standards for in-vitro evaluation of new components and systems of ECC. Diagonal pumps were either set up with non-pulsatile (n = 5, NPG) or pulsatile (n = 5, PG) pump settings and evaluated for 6 h. All analyses were conducted with human whole blood. Blood samples were repeatedly drawn from the test circuits and analyzed regarding free hemoglobin, interleukin 8 (IL-8), platelet aggregation and acquired von Willebrand syndrome (AVWS). Results After 1 h of circulation, a significant coagulation impairment (impaired platelet function and AVWS) was observed in both groups. After 6 h of circulation, increased IL-8 concentrations were measured in both groups (NPG: 0.05 ± 0.03 pg./mL, PG: 0.03 ± 0.01 pg./mL, p = 0.48). Pulsatile pump flow resulted in significantly increased hemolysis after 6 h of circulation (NPG: 37.3 ± 12.4 mg/100 L; PG: 59.6 ± 14.5 mg/100 L; p < 0.05). Conclusion Our results indicate that the coagulative impairment takes place in the early phase of ECC. Pulsatility did not affect the occurrence of AVWS ex-vivo . Prolonged durations of pulsatile pump flow led to increased hemolysis and therefore, its prolonged use should be employed cautiously in clinical practice with appropriate monitoring.
No takes yet. Share an insight, caveat, or question.
Zieger et al. (2023) studied Healthy human whole blood (in-vitro model) (n=10). Pulsatile pump flow vs. Non-pulsatile pump flow was evaluated on Hemolysis (normalized milligram index of hemolysis) at 6 hours (p=0.04). Pulsatile pump flow in an ex-vivo extracorporeal circulation model resulted in increased hemolysis compared to non-pulsatile flow after 6 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: